Molecular profiling identifies targeted therapy opportunities in pediatric solid cancerAlanna J. Church, Katherine A. Janeway, Alma Imamović et al.|Nature Medicine|2022Cited by 65
Race Disparities in Proton Radiotherapy Use for Cancer Treatment in Patients Enrolled in Children’s Oncology Group TrialsDanielle S. Bitterman, Daphne A. Haas‐Kogan, Kira Bona et al.|JAMA Oncology|2020Cited by 36
Long-term follow-up of the first in human post-transcriptional genetic silencing of BCL11A in sickle cell disease in a phase 1 pilot and feasibility trialErica B. Esrick, David A. Williams, Leslie Lehmann et al.|Blood|2025Cited by 1
PNOC014: Phase I Study of Tovorafenib for Children With Relapsed/Recurrent Low-Grade Gliomas and Other Mitogen Activated Protein Kinase Pathway–Activated TumorsKaren Wright, Sabine Mueller, Cassie Kline et al.|JCO oncology advances.|2026Cited by 0